These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16785070)

  • 1. Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
    Carpenter PA; Schubert MM; Flowers ME
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):792-4. PubMed ID: 16785070
    [No Abstract]   [Full Text] [Related]  

  • 2. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
    Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary hypofunction and xerostomia: diagnosis and treatment.
    Atkinson JC; Grisius M; Massey W
    Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
    Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I
    Clin Rheumatol; 2007 Aug; 26(8):1320-7. PubMed ID: 17221146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary enhancement: current status and future therapies.
    Atkinson JC; Baum BJ
    J Dent Educ; 2001 Oct; 65(10):1096-101. PubMed ID: 11699983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y; Kimura Y; Nakamura T
    Ann Rheum Dis; 2004 Jun; 63(6):749. PubMed ID: 15140789
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
    Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
    Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
    Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
    Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
    Chambers MS; Jones CU; Biel MA; Weber RS; Hodge KM; Chen Y; Holland JM; Ship JA; Vitti R; Armstrong I; Garden AS; Haddad R
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1369-76. PubMed ID: 17855005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
    Witsell DL; Stinnett S; Chambers MS
    Head Neck; 2012 Aug; 34(8):1136-42. PubMed ID: 22231734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome.
    Takagi Y; Katayama I; Tashiro S; Nakamura T
    J Rheumatol; 2008 Nov; 35(11):2289-91. PubMed ID: 19004065
    [No Abstract]   [Full Text] [Related]  

  • 12. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
    Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY
    Arch Intern Med; 2002 Jun; 162(11):1293-300. PubMed ID: 12038948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cevimeline (Evoxac) for dry mouth.
    Med Lett Drugs Ther; 2000 Aug; 42(1084):70. PubMed ID: 10932302
    [No Abstract]   [Full Text] [Related]  

  • 14. Unraveling the mysteries of saliva: its importance in maintaining oral health. Transcript of a lecture presented on August 6 at the 2006 AGD Annual Meeting & Exposition.
    Crossley H
    Gen Dent; 2007; 55(4):288-96. PubMed ID: 17682636
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
    Takakura K; Takaki S; Takeda I; Hanaue N; Kizu Y; Tonogi M; Yamane GY
    Bull Tokyo Dent Coll; 2007 May; 48(2):47-56. PubMed ID: 17978545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic strategies for xerostomia in chronic graft versus host disease patients].
    Nagler R
    Harefuah; 2000 Jun; 138(12):1061-4. PubMed ID: 10979435
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies.
    Singhal S; Powles R; Treleaven J; Rattenbury H; Mehta J
    Leuk Lymphoma; 1997 Feb; 24(5-6):539-43. PubMed ID: 9086444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to preventing xerostomia.
    J Support Oncol; 2006 Feb; 4(2):87-8. PubMed ID: 16499130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.